Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Ito

Showing results (101-110 of 191) with videos related to

Pageof 20
Sort By:
The Journal of Experimental Medicine|January 4, 2007
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligandTomoki Ito, Maria Yang, Yui-Hsi Wang, et al.
Immunology|September 30, 2010
Interferon-α and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cellsYuichi Katashiba, Rie Miyamoto, Akira Hyo, et al.
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNsTomoki Ito, Ryuichi Amakawa, Muneo Inaba, et al.
The American Journal of Pathology|December 19, 2020
Decreased Proteasomal Function Induces Neuronal Loss and Memory ImpairmentUtano Tomaru, Tomoki Ito, Yu Ohmura, et al.
Journal of Leukocyte Biology|June 5, 2007
Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cellsTsutomu Tanijiri, Toshiki Shimizu, Kazutaka Uehira, et al.
Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.
Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.
International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.
Pageof 20

Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
The Journal of Experimental Medicine|January 4, 2007
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligandTomoki Ito, Maria Yang, Yui-Hsi Wang, et al.
Immunology|September 30, 2010
Interferon-α and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cellsYuichi Katashiba, Rie Miyamoto, Akira Hyo, et al.
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNsTomoki Ito, Ryuichi Amakawa, Muneo Inaba, et al.
The American Journal of Pathology|December 19, 2020
Decreased Proteasomal Function Induces Neuronal Loss and Memory ImpairmentUtano Tomaru, Tomoki Ito, Yu Ohmura, et al.
Journal of Leukocyte Biology|June 5, 2007
Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cellsTsutomu Tanijiri, Toshiki Shimizu, Kazutaka Uehira, et al.
Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.
Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.
International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.
Pageof 20